Adissu, H. A., Asem, E. K., & Lelievre, S. A. (2007). Three-dimensional cell culture to model epithelia in the female reproductive system. Reproductive Sciences,
(8 suppl), 11–19.CrossRef
Awaya, T. (2005). Common ethical issues in regenerative medicine. Journal of International Bioethique, 16(1–2), 69–75, 192–193.
Balharry, D., Sexton, K., & BéruBé, K. A. (2008). An in vitro approach to assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, formaldehyde and urethane. Toxicology,
Baum, B. J., & Mooney, D. J. (2000). The impact of tissue engineering on dentistry. The Journal of the American Dental Association,
Baylis, F. (2008). Choosing a path: Setting a course for the journey. The American Journal of Bioethics,
Black, J. (1997). Thinking twice about “tissue engineering”. IEEE Engineering in Medicine and Biology Magazine,
Boenink, M. S., Swierstra, T., & Stemerding, D. (2010). Anticipating the interaction between technology and morality: A scenario study of experimenting with humans in bionanotechnology. Studies in Ethics, Law and Technology,
Bredehorn, T., & Rudolph, B. (2002). Legal problems in tissue transplantation. Transplantation Proceedings,
Bubela, T. M., & Caulfield, T. A. (2004). Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers. Canadian Medical Association Journal,
Burri, R. (2007). Deliberating risks under uncertainty: Experience, trust, and attitudes in a Swiss Nanotechnology Stakeholder Discussion Group. Nanoethics,
Burri, R., & Bellucci, S. (2008). Public perception of nanotechnology. Journal of Nanoparticle Research,
Cao, Y., Vacanti, J. P., Paige, K. T., Upton, J., & Vacanti, C. A. (1997). Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plastic and Reconstructive Surgery,
Chan, S., & Harris, J. (2006). Cognitive regeneration or enhancement: The ethical issues. Regenerative Medicine,
Choumerianou, D. M., Dimitriou, H., & Kalmanti, M. (2008). Stem cells: Promises versus limitations. Tissue Engineering Part B: Reviews,
Cogle, C. R., Guthrie, S. M., Sanders, R. C., Allen, W. L., Scott, E. W., & Petersen, B. E. (2003). An overview of stem cell research and regulatory issues. Mayo Clinic Proceedings,
Cooper, M. (2004). Regenerative medicine: Stem cells and the science of monstrosity. Medical Humanities,
Daar, A. S., Bhatt, A., Court, E., & Singer, P. A. (2004). Stem cell research and transplantation: Science leading ethics. Transplantation Proceedings,
Daily Mail Reporter. (2011). US Soldier ‘re-grows leg’ after pioneering injection of pig bladder hormone. Daily Mail
. Accessed 12 June, 2012.
De Vries, R. B., Oerlemans, A., Trommelmans, L., Dierickx, K., & Gordijn, B. (2008). Ethical aspects of tissue engineering: A review. Issue Engineering Part B: Reviews,
Derksen, M. -H. (2008). Engineering flesh, towards professional responsibility for ‘lived bodies’ in tissue engineering. Ph.D. Thesis, Technische Universiteit Eindhoven, Eindhoven.
Derksen, M. -H., & Horstman, K. (2008). Engineering flesh: Towards an ethics of lived integrity. Medicine, Health Care and Philosophy,
Dhai, A., Moodley, J., McQuoid-Mason, D. J., & Rodeck, C. (2004). Ethical and legal controversies in cloning for biomedical research—a South African perspective. South African Medical Journal,
Dickens, B. M., & Cook, R. J. (2007). Acquiring human embryos for stem-cell research. International Journal of Gynaecology and Obstetrics,
Ebbesen, M., & Jensen, T. G. (2006). Nanomedicine: Techniques, potentials, and ethical implications. Journal of Biomedical and Biotechnology,
Edelman, P., McFarland, D., Mironov, V., & Matheny, J. (2005). Commentary: In vitro-cultured meat production. Tissue Engineering,
Enoch, S., Shaaban, H., & Dunn, K. W. (2005). Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material. Journal of Medical Ethics,
EuroSTEC. (2007). European program for soft tissue engineering for congenital birth defects in children. EU contract LSHB-CT-2006-037409.
Faulkner, A., Kent, J., Geesink, I., & FitzPatrick, D. (2006). Purity and the dangers of regenerative medicine: Regulatory innovation of human tissue-engineered technology. Social Science and Medicine,
Fisk, N. M., Roberts, I. A., Markwald, R., & Mironov, V. (2005). Can routine commercial cord blood banking be scientifically and ethically justified? PLOS Medicine,
Garner, J. P. (2002). Tissue engineering and the trauma surgeon. Trauma,
Garner, J. P. (2004). Tissue engineering in surgery. Surgeon,
Gaskell, G., Allum, N., Bauer, M., et al. (2000). Biotechnology and the European public. Nature Biotechnology,
Gassei, K., & Schlatt, S. (2007). Testicular morphogenesis. Annals of the New York Academy of Sciences,
Gavelin, K., Wilson, R., & Doubleday, R. (2007). Democratic technologies? The final report of the Nanotechnology Engagement Group (NEG). London: Involve.
Gilbert, J. L. (2011). The dangers in adopting a tissue-engineering-centric agenda: A president’s perspective. Journal of Biomedical Materials Research, Part A,
Glotz, P., & Bertschi, S. (2006). People, mobiles and society: Concluding insights from an international expert survey. Knowledge, Technology & Policy,
Gordijn, B. (2006). Medical Utopias: Ethical reflections about emerging medical technologies. Leuven: Peeters.
Griffith, L. G., & Swartz, M. A. (2006). Capturing complex 3D tissue physiology in vitro. Nature Reviews Molecular Cell Biology,
Gunning, J. (2005). Umbilical cord cell banking—implications for the future. Toxicology and Applied Pharmacology,
(2 Suppl), 538–543.CrossRef
Hall, V., Stojkovic, P., & Stojkovic, M. (2006). Using therapeutic cloning to fight human disease: A conundrum or reality. Stem Cells,
Hammerman, M. R., & Cortesini, R. (2004). Organogenesis and tissue engineering. Transplant Immunology,
Holm, S. (2006). Are countries that ban human embryonic stem cell research hypocritical? Regenerative medicine,
Ihde, D. (1990). Technology and the life world: From garden to earth. Bloomington: Indiana University Press.
Ihde, D. (2002). Bodies in technology. Minneapolis: University of Minnesota Press.
Iijima, K., Igawa, Y., Imamura, T., Moriizumi, T., Nikaido, T., Konishi, I., et al. (2007). Transplantation of preserved human amniotic membrane for bladder augmentation in rats. Tissue Engineering,
Irvine, D. J., Stachowiak, A. N., & Hori, Y. (2008). Lymphoid tissue engineering: Invoking lymphoid tissue neogenesis in immunotherapy and models of immunity. Seminars in Immunology,
Jean, J., Lapointe, M., Soucy, J., & Pouliot, R. (2009). Development of an in vitro psoriatic skin model by tissue engineering. Journal of Dermatological Science,
Katz, J. (2006). Mobile communication and the transformation of daily life: The next phase of research on mobiles. Knowledge, Technology & Policy,
Kent, J., Faulkner, A., Geesink, I., & FitzPatrick, D. (2006). Culturing cells, reproducing and regulating the self. Body & Society,
Kim, S., & von Recum, H. (2008). Endothelial stem cells and precursors for tissue engineering: Cell source, differentiation, selection, and application. Tissue Engineering Part B: Reviews,
Kirkpatrick, C. J., Fuchs, S., Hermanns, M. I., Peters, K., & Unger, R. E. (2007). Cell culture models of higher complexity in tissue engineering and regenerative medicine. Biomaterials,
Kulinowski, K. (2004). Nanotechnology: From “wow” to “yuck”? Bulletin of Science, Technology & Society,
Kurtzberg, J., Lyerly, A. D., & Sugarman, J. (2005). Untying the Gordian knot: Policies, practices, and ethical issues related to banking of umbilical cord blood. The Journal of Clinical Investigation,
Langer, R., & Vacanti, J. P. (1993). Tissue engineering. Science,
Lassen, J., & Jamison, A. (2006). Genetic technologies meet the public. Science, Technology and Human Values,
Leabu, M. (2011). Principlism versus utilitarianism in translational medicine ethics. StudiaUBB Philosophia,
Levine, A. D. (2010). Insights from patients’ blogs and the need for systematic data on stem cell tourism. American Journal of Bioethics,
Li, G. N., & Hoffman-Kim, D. (2008). Tissue-engineered platforms of axon guidance. Tissue Engineering Part B: Reviews,
Lomax, G. P., Hall, Z. W., & Lo, B. (2007). Responsible oversight of human stem cell research: The California Institute for Regenerative Medicine’s medical and ethical standards. PLoS Medicine,
Longley, D., & Lawford, P. (2001). Engineering human tissue and regulation: Confronting biology and law to bridge the gaps. Medical Law International,
Lowenheim, H., Dazert, S., Bucheler, M., & Guntinas-Lichius, O. (2003). Regenerative medicine/cellular engineering for diseases of the head and neck. DNA and Cell Biology,
Marris, C. (2001). Public views on GMOs: Deconstructing the myths. Stakeholders in the GMO debate often describe public opinion as irrational. But do they really understand the public? EMBO Reports,
Moise, K. J., Jr. (2005). Umbilical cord stem cells. Obstetrics and Gynecology,
Moseley, T. A., Zhu, M., & Hedrick, M. H. (2006). Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plastic and Reconstructive Surgery,
(3 Suppl), 121S–128S.CrossRef
Multi-Agency Tissue Engineering Science (MATES), Interagency Working Group (IWG). (2007). Advancing tissue science and engineering. A foundation for the future. A multi-agency strategic plan. Tissue Engineering, 13(12), 2825–2826.
National Institute of Biomedical Imaging and Bioengineering (NIBIB). (2010). Regenerative Medicine Fact Sheet. http://report.nih.gov/nihfactsheets/Pdfs/RegenerativeMedicine%28NIBIB%29.pdf
. Accessed 12 June, 2012.
Nerem, R. M. (2006). Tissue engineering: The hope, the hype, and the future. Tissue Engineering,
Nieminen, O., & Kurki, P. (2004). Risk management for biological products. International Journal of Pharmaceutical Medicine,
Oerlemans, A. J., Rodrigues, C. H., Verkerk, M. A., van den Berg, P. P., & Dekkers, W. J. (2010). Ethical aspects of soft tissue engineering for congenital birth defects in children—what do experts in the field say? Tissue Engineering Part B Reviews,
Oerlemans, A. J., van den Berg, P. P., van Leeuwen, E., & Dekkers, W. J. (2011). Ethical issues regarding the donation and source of cells for tissue engineering: A European focus group study. Tissue Engineering Part B Reviews,
Oerlemans, A. J. M., Feitz, W. F. J., van Leeuwen, E., & Dekkers, W. J. M. (2012). Regenerative urology clinical trials: An ethical assessment of road blocks and solutions (forthcoming).
Olson, J. L., Atala, A., & Yoo, J. J. (2011). Tissue engineering: Current strategies and future directions. Chonnam Medical Journal,
Orr, S., Alexandre, E., Clark, B., Combes, R., Fels, L. M., Gray, N., et al. (2002). The establishment of a network of European human research tissue banks. Cell Tissue Bank,
Parson, A. (2006). A tissue engineer sows cells and grows organs. New York Times
. Accessed 12 June, 2012.
Pascal, P., Damour, O., Colpart, J. J., & Braye, F. (2000). French legal framework relating to human tissues and cells. Medical & Biological Engineering & Computing,
Patrick, C. W. (2004). Breast tissue engineering. Annual Review of Biomedical Engineering,
Polak, D. J. (2010). Regenerative medicine. Opportunities and challenges: A brief overview. J R Soc Interface, 7(Suppl 6), S777–781.
Poumay, Y., & Coquette, A. (2007). Modelling the human epidermis in vitro: Tools for basic and applied research. Archives of Dermatological Research,
Resnik, D. B. (2002). The commercialization of human stem cells: Ethical and policy issues. Health Care Analysis,
Rogers-Hayden, T., & Pidgeon, N. (2006). Reflecting upon the UK’s Citizen’s Jury on nanotechnologies: NanoJury UK. Nanotechnology, Law and Business, 3(2).
Royal Netherlands Academy of Arts and Sciences (Ed.). (2009). Well underway. Opportunities for regenerative medicine in the Netherlands (Vol. 14, Foresight studies). Amsterdam: KNAW.
Salvaterra, E., Lecchi, L., Giovanelli, S., Butti, B., Bardella, M. T., Bertazzi, P. A., et al. (2008). Banking together. A unified model of informed consent for biobanking. EMBO Reports,
Samanta, A., Samanta, J., & Price, D. (2004). Who owns my body—thee or me? The human tissue story continues. Clinical Medicine,
Satava, R. M. (2003). Biomedical, ethical, and moral issues being forced by advanced medical technologies. Proceedings of the American Philosophical Society,
Schwab, I. R., Johnson, N. T., & Harkin, D. G. (2006). Inherent risks associated with manufacture of bioengineered ocular surface tissue. Archives of Ophthalmology,
Siegelbaum, D. (2008). In search of a test-tube hamburger. Time
. Accessed 12 June, 2012.
Smith, D. S. (2006). The government’s role in advancing regenerative medicine and tissue engineering—science, safety, and ethics. Periodontol,
Sofaer, N., & Eyal, N. (2010). The diverse ethics of translational research. The American Journal of Bioethics,
Solbakk, J. H. (2006). Stem cell research and the ethics of transparency. Regenerative medicine,
Stover, D. (2000). Growing hearts from scratch. Popular Science, 46–50.
Svenaeus, F. (2000). The body uncanny—further steps towards a phenomenology of illness. Medicine, Healthcare and Philosophy,
Svenaeus, F. (2001). The phenomenology of health and illness. In S. Toombs (Ed.), Handbook of phenomenology and medicine
(pp. 87–108). Dordrecht: Kluwer.CrossRef
Swierstra, T., & Rip, A. (2007). Nano-ethics as NEST-ethics: Patterns of moral argumentation about new and emerging science and technology. Nanoethics,
Swierstra, T., & Te Molder, H. (2012). Risk and soft impacts. In S. Roeser, R. Hillerbrand, M. Petersen, & P. Sandin (Eds.), Handbook of risk theory (pp. 1050–1066). Dordrecht: Springer.
Swierstra, T., Stemerding, D., & Boenink, M. (2009). Exploring techno-moral change: The case of the obesity pill. In P. Sollie & M. Düwell (Eds.), Evaluating new technologies, methodological problems for the ethical assessment of technology developments
(pp. 119–138). Dordrecht: Springer.CrossRef
Tanaka, Y., Sato, K., Shimizu, T., Yamato, M., Okano, T., & Kitamori, T. (2007). Biological cells on microchips: New technologies and applications. Biosensors & Bioelectronics,
Thacker, E. (2002). Bio-X: Removing bodily contingency in regenerative medicine. Journal of Medical Humanities,
Thasler, W. E., Weiss, T. S., Schillhorn, K., Stoll, P. T., Irrgang, B., & Jauch, K. W. (2003). Charitable state-controlled foundation human tissue and cell research: Ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany. Cell Tissue Bank,
Thompson, C. (2007). Why we should, in fact, pay for egg donation. Regenerative medicine,
Timothy, C. (2004). Biotechnology and the popular press: Hype and the selling of science. Trends in Biotechnology,
Trewavas, A., & Leaver, C. (2001). Is opposition to GM crops science or politics? EMBO Reports,
Trommelmans, L., & Dierickx, K. (2009). Standard of care in clinical research with human tissue engineered products (HTEPs). The American Journal of Bioethics,
Trommelmans, L., Selling, J., & Dierickx, K. (2007). A critical assessment of the directive on tissue engineering of the European Union. Tissue Engineering,
Trommelmans, L., Selling, J., & Dierickx, K. (2008a). Ethical reflections on clinical trials with human tissue engineered products. Journal of Medical Ethics,
Trommelmans, L., Selling, J., & Dierickx, K. (2008b). Informing participants in clinical trials with ex vivo human tissue-engineered products: What to tell and how to tell it? Journal of Tissue Engineering and Regenerative Medicine,
Trommelmans, L., Selling, J., & Dierickx, K. (2009a). An exploratory survey on the views of European tissue engineers concerning the ethical issues of tissue engineering research. Tissue Enginering Part B Reviews,
Trommelmans, L., Selling, J., & Dierickx, K. (2009b). Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research. Medicine, Health Care and Philosophy,
Trouet, C. (2004). New European guidelines for the use of stored human biological materials in biomedical research. Journal of Medical Ethics,
Tsang, L. (2005). Legal and ethical status of stem cells as medicinal products. Advanced Drug Delivery Reviews,
Tung, L., & Cysyk, J. (2007). Imaging fibrillation/defibrillation in a dish. Journal of Electrocardiology, 40(6, Supplement 1), S62–S65.
Tveit, G., Madsen, K., & Sandoe, P. (2003). Biotechnology and the public. Danish Centre for Bioethics and Risk Assessment.
Tzanakakis, E. S., Hess, D. J., Sielaff, T. D., & Hu, W. S. (2000). Extracorporeal tissue engineered liver-assist devices. Annual Review of Biomedical Engineering,
Vacanti, C. A. (2006). History of tissue engineering and a glimpse into its future. Tissue Engineering,
Van Blitterswijk, C. A., Moroni, L., Rouwkema, J., Siddappa, R., & Sohier, J. (2008). Tissue engineering—an introduction. In C. van Blitterswijk, P. Thomsen, A. Lindahl, J. Hubbell, D.F. Williams, R. Cancedda, J.D. de Bruijn, J. Sohier (Eds.), Tissue Engineering (pp. xii–xxxvi). Burlington: Academic Press.
Van der Burg, S. (2009). Taking the “soft impacts” of technology into account: Broadening the discourse in research practice. Social Epistemology,
Yoshimura, Y. (2006). Bioethical aspects of regenerative and reproductive medicine. Human Cell,
Weiss, G. (1999). Body images: Embodiment as intercorporeality. New York/London: Routledge.